DICOM Controlled Terminology Definitions

Archive device

Autorefraction device

Angioscopy device

Audio object

Ultrasound Bone Densitometry (modality)

Biomagnetic imaging device

Bone Mineral Densitometry by X-Ray (modality), including dual-energy X-Ray absorptiometry (DXA) and morphometric X-Ray absorptiometry (MXA)

Computer Assisted Detection/Diagnosis device

Image Capture Device, includes video capture

Color flow Doppler

Cinefluorography

Computation Server; includes radiotherapy planning

Culposcopy

Computed Radiography device

Cystoscopy

Computed Tomography device

Duplex Doppler

Digital fluoroscopy

Diaphanography device

Digital microscopy

Equipment that digitized hardcopy documents and imported them

Digital Subtraction Angiography

Department System Scheduler, workflow manager; includes RIS

Digital Radiography device

Echocardiography

Electrocardiography device

Cardiac Electrophysiology device

Endoscopy device

Female sex

Fluorescein angiography

Female sex changed to Male sex

Film Digitizer

Female Pseudohermaphrodite

Fundoscopy

General Microscopy device

Hermaphrodite

Hard Copy

Hemodynamic Waveform acquisition device

Intra-oral Radiography device

An acquisition device, process or method that performs intravascular optical coherence tomography

Intravascular Ultrasound device

Keratometry device

Key Object Selection object

Lensometry device

Procedure Logging device; includes cath lab logging

Laparoscopy

Laser surface scan device

Male sex

Magnetic resonance angiography

Male sex changed to Female sex

A device that creates DICOM PS3.10 interchange media; e.g. a CD creator that is managed by the Media Creation Management Service Class

Equipment that retrieved and imported objects from interchange Media

Mammography device

Male Pseudohermaphrodite

Magnetic Resonance device

Magnetic resonance spectroscopy

Instances need to be retrieved from relatively slow media such as optical disk or tape

Nuclear Medicine device

Measurements of the axial length of the eye, which are done by various devices

Modality device that uses an interferometric, non-invasive optical tomographic technique to image 2D slices and 3D volumes of tissue using visible and near visible frequencies

Instances need to be retrieved by manual intervention

Instances are immediately available

Ophthalmic photography modality

Modality device that measures corneal topography, corneal or retinal thickness, and other similar parameters that are typically displayed as maps

Modality device that measures the refractive characteristics of the eye

Tomography of the eye acquired by a modality that is based on light and optical principles. Tomography based on other principles, such as ultrasound, is excluded

Modality device that measures visual fields and perform visual perimetry

An acquisition device, process or method that performs optical surface scanning

Other Modality device

Presentation State object

Hard Copy Print Server; includes printers with embedded DICOM print server

Positron emission tomography (PET) device

Panoramic X-Ray device

Registration

Radiofluoroscopy device

Radiographic imaging (conventional film/screen)

Radiation Therapy Device; includes linear accelerator, proton therapy

Radiotherapy Dose

Radiotherapy Imaging device; includes portal imaging

Radiotherapy Plan

Radiotherapy Treatment Record

Radiotherapy Structure Set

Segmentation

Slide Microscopy

Stereometric image pairing modality

Structured Report Document

Subjective Refraction device

Single-photon emission computed tomography (SPECT) device

Thermography device

Unknown Sex

Instances cannot be retrieved

Ultrasound device

Visual Acuity device

Videofluorography

Equipment that digitizes video tape and imports it

Workstation

X-Ray Angiography device

External-camera Photography device

A signal transmitted for the purpose of interchange of the current time, not specific to any source or methodology

A signal that is generated for each detection of a heart beat

A signal transmitted by the Inter-Range Instrumentation Group for the purpose of synchronizing time clocks

A signal that indicated that X-Ray source has been activated for fluoroscopy use

A signal that indicated that the X-Ray source has been activated for image recording

An electrical signal derived from two electrodes

An electrophysiological recording from the HIS nerve bundle

An electrical signal from one electrode relative to an indifferent potential

The voltage stimulus during cardiac pacing

The power injected during RF ablation procedure

Electrophysiological signals acquired using a multi-splined catheter each equipped with multiple electrodes

Electrophysiological signals acquired using a steerable catheter

A voltage measurement not otherwise specified

A signal point that is 35% of the peak thermal cardiac output signal

A signal point that is 70% of the peak thermal cardiac output signal

The peak pressure of each heart beat in the atrium caused by the atrial contraction

The average of several A wave pressure measurements

An identified cardiac beat used in the determination of a measurement

An identified cardiac beat not used in the determination of a measurement

The average of several diastolic pressure measurements

The lowest pressure value excluding any undershoot artifact

The moment at the end of the diastolic phase of the cardiac cycle

The moment at the end of respiratory expiration

The moment at the end of respiratory inspiration

The maximum positive rate of change of pressure

The maximum negative rate of change of pressure

The average blood pressure value, generally over 2 or more seconds

The peak change in blood temperature during a thermal cardiac output measurement

The moment respiratory expiration begins

The moment of respiratory inspiration begins

The first discernible blood temperature change following the injectate during a thermal cardiac output measurement

The average of several systolic blood pressure measurements

The highest systolic blood pressure value excluding any overshoot artifact

The peak pressure of each heart beat in the atrium caused by the filling of the atrium

The average of several V wave pressure measurements

The moment at which a heart valve closes

The moment at which a heart valve opens

The moment when RF ablation current is turned off

The moment when RF ablation current is turned on

The moment in the cardiac cycle when the HIS bundle nerves depolarize

The surface electrocardiogram of the atrial contraction

The first negative deflection of the electrocardiogram caused by ventricular depolarization

The first positive deflection the electrocardiogram caused by ventricular depolarization

The first negative deflection after the R wave

The beginning of the atrial contraction

The beginning of the second atrial contraction of two consecutive beats

The stimulation interval during cardiac stimulation first used in a pacing train

The stimulation interval different from the first stimulation interval used in a pacing train

A stimulation interval different from and subsequent to the second interval in a pacing train

Describes a stimulation interval different from and subsequent to the third interval in a pacing train

The electrocardiogram deflection caused by ventricular repolarization

The peak pressure of each heart beat monitored in the atrium caused by the filling of the atrium

The second V wave measurement of two consecutive beats

A description of the physiological condition of the patient

The exercise level during a progressive cardiac stress test

A series of physiological challenges designed to progressively increase the work of the heart

A subpart of a cardiac catheterization procedure

The subpart of a cardiac catheterization procedure in which a radio-opaque contrast medium is injected into the patient

Physical changes administered to a patient in order to elicit an physiological response

Enumeration of a subpart of a catheterization procedure

A subpart of an electrophysiological procedure

A means of defining a series of cardiac stimulation pulses

End of the contraction phase of the cardiac cycle

Time for a median particle to travel from point of injection to point of detection

The time constant of isovolumic pressure fall

Maximum velocity of myocardial contractility

Total time for the acquisition is shorter than cardiac cycle, no gating is applied; see Cardiac Synchronization Technique (0018,9037)

Certain thresholds have been set for a gating window that defines the acceptance of measurement data during the acquisition; see Cardiac Synchronization Technique (0018,9037)

Certain thresholds have been set for a gating window that defines the acceptance of measurement data after the acquisition; see Cardiac Synchronization Technique (0018,9037)

There is a constant RR interval, which makes thresholding not required; see Cardiac Synchronization Technique (0018,9037); e.g. Pacemaker

Imaging after injection of tracer during increased cardiac workload or increased myocardial blood flow, achieved by either exercise or pharmacologic means

Imaging after injection of additional tracer under resting conditions

Imaging after allowing a moderate amount of time for tracer to move from its initial sites of uptake. Example: For Thallium imaging this would correspond to imaging 2-6 hours after injection

Imaging after allowing an extended amount of time for tracer to move from its initial sites of uptake. Example: For Thallium imaging this would correspond to imaging more than 6 hours after injection

Peak cardiac stress state

Recovery from cardiac stress

Equipment that originally acquired the data stored within composite instances; e.g. a CT, MR or Ultrasound modality

Equipment that has processed composite instances to create new composite instances; e.g. a 3D Workstation

Equipment that has modified existing composite instances (without creating new composite instances); e.g. a QA Station or Archive

Equipment that has modified an existing composite instance to remove patient identifying information

Equipment that has processed composite instances to create new composite instances by extracting selected frames from the original instance

Equipment that has processed composite instances to create new composite instances by converting classic single frame images to enhanced multi-frame image, or vice versa and updating other instances to maintain referential integrity

The sound of a human's speech, recorded during a procedure

The voice of a device operator, recorded during a procedure

The ambient sound recorded during a procedure, which may or may not include voice and other types of sound

The Doppler waveform recorded as an audible signal

The sound of the human heart beating

Any sound made by the human body

A digitized signal from the patient arterial system collected through pulse oximetry or other means

A digitized signal from the patient respiratory system representing respiration

The occasion on which a procedure was performed on admission to a specialist unit; e.g. intensive care

The occasion on which a procedure was performed on discharge from hospital as an in-patient

The occasion on which a procedure was performed on discharge from a specialist unit; e.g. intensive care

The occasion on which a procedure was performed immediately prior to non-surgical intervention; e.g, percutaneous angioplasty, biopsy

The occasion on which a procedure was performed immediately after to non-surgical intervention; e.g, percutaneous angioplasty, biopsy

The occasion on which a procedure was performed at the most recent outpatient visit

The active or passive joint positioning during acquisition

A physical force applied during acquisition

Prior to voiding

Post voiding

Neutral musculoskeletal position

America Kennel Club

America's Pet Registry Inc

American Canine Association

American Purebred Registry

American Rare Breed Association

Animal Registry Unlimited

Animal Research Foundation

Canadian Border Collie Association

Canadian Kennel Club

Canadian Livestock Records Association

Canine Federation of Canada

Continental Kennel Club

Dog Registry of America

Federation of International Canines

International Progressive Dog Breeders' Alliance

National Kennel Club

North American Purebred Dog Registry

United All Breed Registry

United Kennel Club

Universal Kennel Club International

Working Canine Association of Canada

World Kennel Club

World Wide Kennel Club

Evaluation of overall image quality as described in section 7.3.2 of [IEC 62563-1]

Visual verification of sufficient grayscale resolution based on 8 and 10-bit markers as described in section 7.3.3 of [IEC 62563-1]

Visual evaluation of luminance response using the TG18-CT test pattern as described in section 7.3.4 of [IEC 62563-1]

Visual detection of luminance non-uniformities as described in section 7.3.5 of [IEC 62563-1]

Visual verification of color uniformity as described in section 7.3.6 of [IEC 62563-1]

Visual detection of defective pixels on dark (TG18-UN80) and bright (TG18-UN10) images as described in section 7.3.7 of [IEC 62563-1]

Visual evaluation of veiling glare by looking at low contrast objects on 2 test patterns as described in section 7.3.8 of [IEC 62563-1]

Visual evaluation of geometry, phase/clock correction and clipping as described in section 7.3.9 of [IEC 62563-1]

Visual evaluation of viewing angle as described in section 7.3.10 of [IEC 62563-1]

Visual evaluation of the appearance of clinical images as described in section 7.3.11 of [IEC 62563-1]

AAPM TG18-QC Pattern used for evaluation of resolution, luminance, distortion, artifacts. See [AAPM OR 03]

AAPM TG18-BR Pattern used for the evaluation of the display of low-contrast, fine-detail image structures See [AAPM OR 03]

AAPM TG18-PQC Pattern used for evaluation of resolution, luminance, contrast transfer for prints. See [AAPM OR 03]

AAPM TG18-CT Pattern used for evaluation of luminance response. See [AAPM OR 03]

The 1st image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 2nd image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 3rd image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 4th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 5th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 6th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 7th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 8th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 9th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 10th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration series. See [AAPM OR 03]

The 11th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 12th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 13th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 14th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 15th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 16th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 17th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 18th image in the AAPM TG18-LN8- set used for DICOM grayscale calibration. See [AAPM OR 03]

The 1st image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 2 nd image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 3rd image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 4th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 5th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 6th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 7th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 8th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 9th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 10th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 11th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 12th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 13th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 14th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 15th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 16th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 17th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The 18th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]

The AAPM TG18-UN10 Pattern used for evaluation of luminance and color uniformity, and angular response. See [AAPM OR 03]

The AAPM TG18-UN80 Pattern used for evaluation of luminance and color uniformity, and angular response. See [AAPM OR 03]

The AAPM TG18-UNL10 Pattern is the AAPM TG-18 UN10 Pattern with added defining lines. See [AAPM OR 03]

The AAPM TG18-UNL80 Pattern is the AAPM TG-18 UN80 Pattern with added defining lines. See [AAPM OR 03]

The AAPM TG18-AD Pattern used for visual evaluation of the reflection of ambient light from the display. See [AAPM OR 03]

The AAPM TG18-MP Pattern used for evaluation of Luminance response (bit-depth resolution). See [AAPM OR 03]

The AAPM TG18-RH10 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 10% luminance level. See [AAPM OR 03]

The AAPM TG18-RH50 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 50% luminance level. See [AAPM OR 03]

The AAPM TG18-RH89 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 89% luminance level. See [AAPM OR 03]

The AAPM TG18-RV10 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 10% luminance level. See [AAPM OR 03]

The AAPM TG18-RV50 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 50% luminance level. See [AAPM OR 03]

The AAPM TG18-RV89 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 89% luminance level. See [AAPM OR 03]

The AAPM TG18-PX Pattern used for the assessment of display resolution. See [AAPM OR 03]

The AAPM TG18-CX Pattern used to assess display resolution and resolution uniformity. See [AAPM OR 03]

The AAPM TG18-LPH10 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]

The AAPM TG18-LPH50 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 50% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]

The AAPM TG18-LPH89 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 89% background level of the maximum pixel value. See [AAPM OR 03]

The AAPM TG18-LPV10 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]

The AAPM TG18-LPV50 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 50% background level of the maximum pixel value. See [AAPM OR 03]

The AAPM TG18-LPV89 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 89% background level of the maximum pixel value. See [AAPM OR 03]

The AAPM TG18-AFC Pattern used to assess display noise. See [AAPM OR 03]

The AAPM TG18-NS10 Pattern is AAPM TG18-RV10/RH10 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]

The AAPM TG18-NS50 Pattern is AAPM TG18-RV50/RH50 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]

The AAPM TG18-NS89 Pattern is AAPM TG18-RV89/RH89 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]

The TG18-GV Pattern used to assess display veiling. See [AAPM OR 03]

The TG18-GVN Pattern used to assess display veiling. This pattern is identical to AAPM TG18-GV Pattern except that the large-diameter white circle is replaced with a black circle, creating a completely black pattern except for the presence of low-contrast targets. See [AAPM OR 03]

The TG18-GQ Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GV except that is lacks the central low-contrast objects. See [AAPM OR 03]

TG18-GQN Pattern used for the quantitative assessment of veiling glare. This pattern is identical to AAPM TG18-GQ Pattern except that the large-diameter white circle is replaced with a black circle, creating a completely black pattern except for the presence of low-contrast targets. See [AAPM OR 03]

The TG18-GQB Pattern used for the quantitative assessment of veiling glare. This pattern is identical to AAPM TG18-GQ Pattern except eliminating the central black circle. See [AAPM OR 03]

The TG18-GA03 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 3. See [AAPM OR 03]

The TG18-GA05 Pattern This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 5. See [AAPM OR 03]

The TG18-GA08 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 8. See [AAPM OR 03]

The TG18-GA10 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 10. See [AAPM OR 03]

The TG18-GA15 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 15

The TG18-GA20 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 20. See [AAPM OR 03]

The TG18-GA25 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 25. See [AAPM OR 03]

The TG18-GA30 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 30. See [AAPM OR 03]

The AAPM TG18-CH Image is a reference anatomical PA chest image. See [AAPM OR 03]

The AAPM TG18-KN Image is a reference anatomical knee image. See [AAPM OR 03]

The AAPM TG18-MM1 Image is a reference anatomical mammogram image. See [AAPM OR 03]

The AAPM TG18-MM2 Image is a reference anatomical mammogram image. See [AAPM OR 03]

The IEC OIQ Pattern is used as an alternative to the TG18-QC Pattern. See [IEC 62563-1]

The IEC ANG Pattern used for angular viewing evaluation. See [IEC 62563-1]

The IEC GD Pattern used for geometrical image evaluation. See [IEC 62563-1]

The IEC BN01 Pattern is used as analternative to the TG18-LN-01 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN02 Pattern is used as analternative to the TG18-LN-02 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN03 Pattern is used as analternative to the TG18-LN-03 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN04 Pattern is used as analternative to the TG18-LN-04 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN05 Pattern is used as analternative to the TG18-LN-05 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN06 Pattern is used as analternative to the TG18-LN-06 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN07 Pattern is used as analternative to the TG18-LN-07 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN08 Pattern is used as analternative to the TG18-LN-08 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN09 Pattern is used as analternative to the TG18-LN-09 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN10 Pattern is used as analternative to the TG18-LN-10 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN11 Pattern is used as analternative to the TG18-LN-11 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN12 Pattern is used as analternative to the TG18-LN-12 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN13 Pattern is used as analternative to the TG18-LN-13 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN14 Pattern is used as analternative to the TG18-LN-14 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN15 Pattern is used as analternative to the TG18-LN-15 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN16 Pattern is used as analternative to the TG18-LN-16 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN17 Pattern is used as analternative to the TG18-LN-17 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

The IEC BN18 Pattern is used as analternative to the TG18-LN-18 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]

Test image "Bild 2" for the gray-scale reproduction of imaging devices. See [DIN 6868-57]

Test image "Bild 3" for the geometrical imaging properties of imaging devices. See [DIN 6868-57]

Test image "Bild 5" for displaying the spatial and contrast resolution as well as the line structure of imaging devices. See [DIN 6868-57]

An alternative to AAPM TG18-UN80, specified at 100% of maximum pixel value

A standard display test pattern. See [SMPTE RP133]. A pattern is available at http://www.dclunie.com/images/smpte.512.512.8.gif

A Display Device that displays images on a Cathode Ray Tube

A Display Device that displays images on a Liquid Crystal Display

A Display Device that displays images on a Plasma Display

A Display Device that displays images on an Organic Light Emitting Diode based display

A Display Device that projects images on a surface from behind using a Digital Light Processing Projector

A Display Device that projects images on a surface from in front using a Digital Light Processing Projector

A Display Device that projects images on a surface from behind using a Cathode Ray Tube

A Display Device that projects images on a surface from in front using a Cathode Ray Tube

A Display Device that projects images on a surface from an unspecified direction using an unspecified means

Image processing work item

Quality control work item

Computer aided diagnosis work item

Computer aided detection work item

Interpretation work item

Transcription work item

Report verification work item

Print work item

There will be no more work items scheduled

Film type of output

Dictation type of output

Transcription type of output

The procedure to read DICOM instances from DICOM interchange media, coerce identifying attributes into the local namespace if necessary, and make the instances available

Digitization of Sheet Film

Digitization of Cine Film

Digitization of Video Tape

Digitization of pages of a paper document (Units may be specified as Pages, Documents)

Importation of CD

Importation of DVD

Importation of MOD

Importation of DICOM Studies

Importation of DICOM Composite Instances

A device that connects using the USB hard drive interface. These may be USB-Sticks, portable hard drives, and other technologies

Email and email attachments used as a media for data transport

CD-R, CD-ROM, and CD-RW media used for data transport

DVD, DVD-RAM, and other DVD formatted media used for data transport

Media that comply with the Compact Flash standard

Media that comply with the Multi-media Card standard

Media that comply with the Secure Digital Card standard

URI Identifier for network or other resource, see RFC 3968

Any paper or similar document

Audit event: Application Activity has taken place

Audit event: Audit Log has been used

Audit event: Storage of DICOM Instances has begun

Audit event: DICOM Instances have been created, read, updated, or deleted

Audit event: Storage of DICOM Instances has been completed

Audit event: Entire Study has been deleted

Audit event: Data has been exported out of the system

Audit event: Data has been imported into the system

Audit event: System has joined or left network

Audit event: Order has been created, read, updated or deleted

Audit event: Patient Record has been created, read, updated, or deleted

Audit event: Procedure Record has been created, read, updated, or deleted

Audit event: Query has been made

Audit event: Security Alert has been raised

Audit event: User Authentication has been attempted

Audit event: Application Entity has started

Audit event: Application Entity has stopped

Audit event: User login has been attempted

Audit event: User logout has been attempted

Audit event: Node has been attached

Audit event: Node has been detached

Audit event: Node Authentication has been attempted

Audit event: Emergency Override has started

Audit event: Network configuration has been changed

Audit event: Security configuration has been changed

Audit event: Hardware configuration has been changed

Audit event: Software configuration has been changed

Audit event: A use of a restricted function has been attempted

Audit event: Audit recording has been stopped

Audit event: Audit recording has been started

Audit event: Security attributes of an object have been changed

Audit event: Security roles have been changed

Audit event: Security attributes of a user have been changed

Audit event: Emergency Override has Stopped

Audit event: Remote Service Operation has Begun

Audit event: Remote Service Operation has Stopped

Audit event: Local Service Operation has Begun

Audit event: Local Service Operation Stopped

Audit participant role ID of software application

Audit participant role ID of software application launcher, i.e., the entity that started or stopped an application

Audit participant role ID of the receiver of data

Audit participant role ID of the sender of data

Audit participant role ID of media receiving data during an export

Audit participant role ID of media providing data during an import

ParticipantObjectID type: Study Instance UID

ParticipantObjectID type: SOP Class UID

ID of a node that is a participant object of an audit message

System, organization, agency, or department that has assigned an instance identifier (such as placer or filler number, patient or provider identifier, etc.)

Procedure order canceled by requesting physician or other authorized physician

Equipment failure prevented completion of procedure

Procedure discontinued due to incorrect procedure being ordered

Procedure discontinued due to patient allergy to media/contrast (reported or reaction)

Procedure discontinued due to death of Patient

Procedure discontinued due to patient refusal to continue procedure

Procedure discontinued due to patient being taken for treatment or surgery

Patient did not arrive for procedure

Procedure discontinued due to patient pregnancy (reported or determined)

Procedure discontinued to restart with new procedure code for correct charging

Procedure discontinued due to duplicate orders received for same procedure

Procedure order canceled by nursing unit

Procedure discontinued due to incorrect side (laterality) being ordered

Procedure discontinued for unspecified reason

Procedure discontinued due to incorrect patient or procedure step selected from modality worklist

Patient condition prevented continuation of procedure

Procedure step is discontinued to change to other equipment or modality

A movement of the patient affecting test quality

An error of the operator affecting test quality

One or more of the objects is malformed

Receiving System is unable to accept the object type

One or more objects associated with the object set is missing

The contents of the Media could not be accessed properly

Procedure discontinued due to necessary equipment, staff or other resource becoming (temporarily) unavailable to the procedure

Procedure discontinued due to necessary equipment, staff or other resource being inadequate to complete the procedure

A new Procedure Step has been scheduled to replace the Discontinued Procedure Step

It is recommended that a new Procedure Step be scheduled to replace the Discontinued Procedure Step

Ventral structures of the diencephalon that cannot readily be distinguished on MR imaging, including the hypothalamus, mammillary body, subthalamic nuclei, substantia nigra, red nucleus, lateral geniculate nucleus, medial geniculate nucleus, zona incerta, cerebral peduncle, lenticular fasciculus, medial lemniscus, and optic tract. See http://neuromorphometrics.org:8080/Seg/html/segmentation/ventral%20diencephalon.html

Area(s) of reduced intensity on T1 weighted images relative to the surrounding white matter. These may be indicative of age-related or neurodegenerative white matter lesions, and may be co-located with areas of white matter T2 hyperintensity, but the concept is specifically confined to the MR appearance on T1 weighted images

Area(s) of increased intensity on T2 weighted images relative to the surrounding white matter. These may be indicative of age-related or neurodegenerative white matter lesions, and may be co-located with areas of white matter T1 hypointensity, but the concept is specifically confined to the MR appearance on T2 weighted images

The dorsal component of the SLF originating from the medial and dorsal parietal cortex and ending in the dorsal and medial part of the frontal lobe. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186

The major component of the SLF, derived from the caudal-inferior parietal region corresponding to the angular gyrus in the human and terminating within the dorsolateral frontal region. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186

The ventral component of the SLF, originating from the supramarginal gyrus and terminating predominantly in the ventral premotor and prefrontal areas. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186

White matter that surrounds a lesion of interest; e.g. to identify the otherwise unclassified white matter that surrounds a tumor to be surgically resected

Signal intensity of a Spin tagging Perfusion MR image. Spin tagging is a technique for the measurement of blood perfusion, based on magnetically labeled arterial blood water as an endogenous tracer

Signal intensity of a Contrast Agent Angio MR image

Signal intensity of a Time-of-flight (TOF) MR image. Time-of-flight (TOF) is based on the phenomenon of flow-related enhancement of spins entering into an imaging slice. As a result of being unsaturated, these spins give more signal that surrounding stationary spins

Signal intensity of a Proton Density Weighted MR image. All MR images have intensity proportional to proton density. Images with very little T1 or T2 weighting are called 'PD-weighted'

Signal intensity of T1 Weighted MR image. A T1 Weighted MR image is created typically by using short TE and TR times

Signal intensity of a T2 Weighted MR image. T2 Weighted image contrast state is approached by imaging with a TR long compared to tissue T1 (to reduce T1 contribution to image contrast) and a TE between the longest and shortest tissue T2s of interest

Signal intensity of a T2* Weighted MR image. The T2* phenomenon results from molecular interactions (spin spin relaxation) and local magnetic field non-uniformities, which cause the protons to precess at slightly different frequencies

Signal intensity of a Field Map MR image. A Field Map MR image provides a direct measure of the B 0 inhomogeneity at each point in the image

Coefficient reflecting the fractional anisotropy of the tissues, derived from a diffusion weighted MR image. Fractional anisotropy is proportional to the square root of the variance of the Eigen values divided by the square root of the sum of the squares of the Eigen values

Coefficient reflecting the relative anisotropy of the tissues, derived from a diffusion weighted MR image

Dxx Component of the diffusion tensor, quantifying the molecular mobility along the X axis

Dxy Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Y directions

Dxz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Z directions

Dyy Component of the diffusion tensor, quantifying the molecular mobility along the Y axis

Dyz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the Y and Z directions

Dzz Component of the diffusion tensor, quantifying the molecular mobility along the Z axis

Signal intensity of a T1 Weighted Dynamic Contrast Enhanced MR image. A T1 Weighted Dynamic Contrast Enhanced MR image reflects the dynamics of diffusion of the exogenous contrast media from the blood pool into the extra vascular extracellular space (EES) of the brain at a rate determined by the blood flow to the tissue, the permeability of the Brain Blood Barrier (BBB), and the surface area of the perfusing vessels

Signal intensity of a T2 Weighted Dynamic Contrast Enhanced MR image. A T2 Weighted Dynamic Contrast Enhanced MR image reflects the T2 of tissue decrease as the Gd contrast agent bolus passes through the brain

Signal intensity of a T2* Weighted Dynamic Contrast Enhanced MR image. A T2* Weighted Dynamic Contrast Enhanced MR image reflects the T2* of tissue decrease as the Gd contrast agent bolus passes through the brain

Signal intensity of a Blood Oxygenation Level image. BOLD imaging is sensitive to blood oxygenation (but also to cerebral blood flow and volume). This modality is essentially used for detecting brain activation (functional MR)

Accumulated decay event counts in a nuclear medicine projection image

Accumulated decay event counts in a Nuclear Medicine Tomographic image (including PET)

Spatial Displacement along axis X of a non-linear deformable spatial registration image. The X axis is defined in reference to the patient's orientation, and is increasing to the left hand side of the patient

Spatial Displacement along axis Y of a non-linear deformable spatial registration image. The Y axis is defined in reference to the patient's orientation, and is increasing to the posterior side of the patient

Spatial Displacement along axis Z of a non-linear deformable spatial registration image. The Z axis is defined in reference to the patient's orientation, and is increasing toward the head of the patient

Measured resistance to the flow of blood; e.g. through the vasculature or through a heart value

Measured resistance to the flow of blood; e.g. through the vasculature or through a heart value, normalized to a particular indexed scale

Velocity of tissue based on Doppler measurements

Velocity of blood flow based on Doppler measurements

Statistical variance of blood velocity relative to mean

Scalar value related to the elastic properties of the tissue

Scalar value related to the volume of blood perfusing into tissue

Speed of sound in tissue

Reduction in strength of ultrasound signal as the wave

Red component of a true color image (RGB)

Green component of a true color image (RGB)

Blue component of a true color image (RGB)

Y (Luminance) component of a YBR FULL image, as defined in JPEG 2000

CB (Blue chrominance) component of a YBR FULL image, as defined in JPEG 2000

CR (Red chrominance) component of a YBR FULL image, as defined in JPEG 2000

Y (Luminance) component of a YBR PARTIAL image, as defined in JPEG 2000

CB (Blue chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000

CR (Red chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000

Y (Luminance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000

CB (Blue chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000

CR (Red chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000

Y (Luminance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000

CB (Blue chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000

CR (Red chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000

The ability of a material to create an ultrasound return echo

Decrease in the number of photons in an X-Ray beam due to interactions with the atoms of a material substance. Attenuation is due primarily to two processes, absorption and scattering

Coefficient that describes the fraction of a beam of X-Rays or gamma rays that is absorbed or scattered per unit thickness of the absorber. This value basically accounts for the number of atoms in a cubic cm volume of material and the probability of a photon being scattered or absorbed from the nucleus or an electron of one of these atoms

Signal intensity of an MR image, not otherwise specified

Binary value denoting that the segmented property is present

Probability, defined as a percentage, that the segmented property occupies the spatial area defined by the voxel

Percentage of the voxel area occupied by the segmented property

Spatial dimension, denoting a linear displacement

Dimension denoting the energy (frequency or wavelength) of photons

Dimension used to sequence events, to compare the duration of events and the intervals between events

Spatial dimension, denoting an angle

A spatial dimension axis running along a line between the patient's left and right side

A spatial dimension axis running along a line between the patient's head and foot

A spatial dimension axis running along a line between the patient's anterior and posterior sides

A spatial dimension axis running along a line between the apex and base of an organ, object, or chamber

A spatial dimension axis running along a line between the anterior and inferior sides of an organ, object, or chamber

A spatial dimension axis running along a line between the septum and wall of a chamber

Orientation of a spatial dimension where increasing values run from the right to the left side of the patient

Orientation of a spatial dimension where increasing values run from the left to the right side of the patient

Orientation of a spatial dimension where increasing values run from the head to the foot of the patient

Orientation of a spatial dimension where increasing values run from the foot to the head of the patient

Orientation of a spatial dimension where increasing values run from the anterior to the posterior side of the patient

Orientation of a spatial dimension where increasing values run from the posterior to the anterior side of the patient

Orientation of a spatial dimension where increasing values run from the apex to the base

Orientation of a spatial dimension where increasing values run from the base to the apex

Orientation of a spatial dimension where increasing values run from the anterior to the inferior

Orientation of a spatial dimension where increasing values run from the inferior to the anterior

Orientation of a spatial dimension where increasing values run from the septum of a chamber to the opposite wall

Orientation of a spatial dimension where increasing values run from the opposite wall to the septum of a chamber

The x coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system

The y coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system

The z coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system

The x value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system

The y value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system

The z value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system

The x value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system

The y value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system

The z value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system

Number of rows in the pixel data of the image

Number of columns in the pixel data of the image

The name assigned by a manufacturer to a specific software algorithm

The input parameters used by a manufacturer to configure the behavior of a specific software algorithm

The software version identifier assigned by a manufacturer to a specific software algorithm

The type of correlation applied to detection results; e.g. temporal, spatial

Assignment of intermediate or overall interpretation results to a general category

Assessment of annotating tissues in breast; generally including fatty, mixed or dense

Purpose of reference for an SCOORD content item that is an outline of the breast that includes the pectoral muscle tissue

The type of distribution associated with detected calcifications

Identification of the morphology of detected calcifications

Purpose of reference for an SCOORD content item that identifies the central point of a finding or feature

The likelihood that the feature analyzed is in fact the type of feature identified

The likelihood that the finding detected is in fact the type of finding identified

The certainty that a device places on an impression, where 0 equals no certainty and 100 equals certainty

A location identifier based on clock-face numbering or anatomic sub-region

An item that is an inferred correlation relating two or more individual findings or features

The inferred relationship between the findings or features making up a composite feature

General assessment of whether or not CAD processing was successful, and whether any findings resulted

The date the data creation started

The time the data creation started

A location identifier based on a feature's inferred distance from the surface of the associated anatomy

A textual description of the change that occurred over time in a qualitative characteristic of a feature

The type of finding sought after by a specific algorithm applied to one image

A general change that occurred within an imaged area between a prior imaging procedure and the current imaging procedure

A group of analysis algorithms that were attempted, but failed

A group of detection algorithms that were attempted, but failed

For projection radiography, the horizontal physical distance measured at the front plane of an Image Receptor housing between the center of each pixel. For tomographic images, the horizontal physical distance in the patient between the center of each pixel

Laterality of (possibly paired) body part contained in an image

A container that references all image data used as evidence to produce a report

A numeric value in the range 0 to 100, inclusive, where 0 is worst quality and 100 is best quality

Purpose of reference for an SCOORD content item that identifies a specific region of interest within an image

The projection of the anatomic region of interest on an image receptor

Modifier for Image View

Free-form text describing the overall or an individual impression

A container for a group of related results from interpretation of one or more images and associated clinical information

The X-Ray attenuation of a lesion relative to the expected attenuation of an equal volume of fibroglandular breast tissue

A structured report containing the results of computer-aided detection or diagnosis applied to breast imaging and associated clinical information

The characteristic of the boundary, edges or border of a detected lesion

The quantity of calcifications detected within an identified group or cluster

A non-lesion object identified within one or more images

Purpose of reference for a COMPOSITE content item that identifies it as the original source of evidence for another content item in the report

Purpose of reference for an SCOORD content item that identifies the outline or bounding region of a finding or feature

The inferred type of disease associated with an identified feature

The patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive column axis (top to bottom)

The patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive row axis (left to right)

Purpose of reference for an SCOORD content item that is an outline of the pectoral muscle tissue only

Percent of breast area that is mammographically dense, excluding pectoralis muscle

The likelihood that an identified finding or feature is cancerous

A location identifier based on the division of an area into four regions

A qualitative characteristic of a feature that has changed over time

The effect of the quality of an image on its usability

The quality control standard used to make a quality assessment

A specific quality related deficiency detected within an image

Recommended type of follow-up to an imaging procedure, based on interpreted results

Recommended follow-up date to an imaging procedure, based on interpreted results

Recommended follow-up interval to an imaging procedure, based on interpreted results

The recommendation of the producer of a content item regarding presentation of the content item by recipients of the report

An indication of how widespread the detection of a feature is within the analyzed image data set

A textual description of the contents of a selected region identified within an image

An item that was detected on one image

Date on which the acquisition of the study information was started

Time at which the acquisition of the study information was started

A group of analysis algorithms that were attempted and completed successfully

A group of detection algorithms that were attempted and completed successfully

An overall indication of whether the CAD detection algorithms applied were completed successfully

An overall indication of whether the CAD analysis algorithms applied were completed successfully

For projection radiography, the vertical physical distance measured at the front plane of an Image Receptor housing between the center of each pixel. For tomographic images, the vertical physical distance in the patient between the center of each pixel

A radiographic projection that has been with the patient lying on a table with the X-Ray source on one side of the table and the detector on the other; e.g. may describe a cross-table cervical spine, chest or pelvis X-Ray image

One of a number of discrete points on the Receiver-Operator Characteristics (ROC) curve that reflects the expected sensitivity and specificity of a CAD algorithm, where zero indicates the highest specificity, lowest sensitivity operating point. The value should not exceed the Maximum CAD Operating Point

The maximum value of CAD Operating Point for the specific CAD algorithm used

The intended interpretation of a CAD Operating Point

The number of false CAD markers per image. Correlates to inverse of Image Specificity

The number of false markers per collection of images that are CAD processed as a group. Correlates to inverse of Case Specificity

The percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in at least one view

The percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in each view

The percentage of cases (collections of images CAD processed as a group) without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Case

The percentage of images without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Image

The CAD operating point that is recommended for initial display by the creator of the structured report

A list of CAD operating points including their corresponding characteristics

A specific area of interest noted within an image

The surface shape of all or a portion of breast related anatomy

Image quality incorporates the following clinical image evaluation parameters: assessment of positioning, compression, artifacts, exposure, contrast, sharpness, and labeling

A finding or feature that is identified as a non-anatomic foreign object

A space-occupying lesion identified in a single image or projection

A single identified calcification

Multiple calcifications identified as occupying a small area of tissue (less than 2 cc)

Straightening or thickening of Cooper's ligaments

An abnormality noted at imaging within the dermis of the breast

An abnormality noted at imaging on the epidermis of the breast

An assessment category to indicate that images have been acquired to assess marker placement following a breast interventional procedure

An indication that the patient should seek post procedural follow-up directives from a clinical health care provider

A recommendation on a patient with known cancer to take steps appropriate to the diagnosis

Positioning of a radiopaque marker

Patient has previous diagnosis of breast cancer resulting in mastectomy

Patient has had biopsy containing proven malignancy

Patient has a finding of mass reported on a prior imaging exam

A breast imaging procedure performed on a specific area of the breast

A breast imaging procedure performed on the entire breast

A cluster of tiny anechoic foci each smaller than 2-3 mm in diameter with thin (less than 0.5 mm) intervening septations and no discrete solid components

A fluid filled mass most commonly characterized by homogeneous low-level internal echoes on ultrasound

Views not inclusive of MLO and CC (BI-RADS®)

A spot or coned down compression of the breast providing a reduction in the thickness and a magnification of the localized area of interest and improved separation of breast tissue

Use of sound waves to visualize muscles, tendons, and many internal organs, to capture their size, structure and any pathological lesions with real time tomographic images.

Obtain previous mammography studies to compare to present study

A medical procedure used for the sampling of mammary duct tissue

Follow up study at 12 months for women 40 years of age having a prior negative study and no mitigating risk factors for breast cancer

Any decision to perform tissue acquisition should be based on clinical assessment

Follow-up at short interval (1-11 months)

Tissue acquisition should be considered

Breast tissue acquisition following the identification of an area of concern with the placement of a needle or needle-wire assembly

Pathologic analysis of breast tissue and lesions using core tissue samples

Lesions that do not have the characteristic morphologies of breast cancer but have a definite probability of being malignant. There is a sufficient concern to urge a biopsy

Cellular analysis of specimen

Tissue acquisition should be strongly considered

Lesions have a high probability of being cancer, which require additional action

The producer of a report intends for a recipient of the report to present or display the associated content item

The producer of a report considers the presentation or display of the associated content item by a recipient to be optional

The producer of a report intends for a recipient of the report NOT to present or display the associated content item

The associated content items are identified as being the same finding or feature at different points in time

The associated content items are identified as being the same finding or feature on different projections taken at the same point in time

The associated content items are identified as being related side-to-side

There is one image in the interpreted data set

There is more than one image of the same modality in the interpreted data set

There is more than one image of the same modality in the interpreted data set

The interpreted data set contains images from multiple modalities

The fibrous tissue replacing normal tissues destroyed by disease or injury

A medical appliance used for localization of non palpable breast lesions to insure that the proper area is removed in a surgical biopsy

A medical appliance used for regulating cardiac rhythms

A compression device used for obtaining mammographic images

A device used for restricting an X-Ray beam

An area designated on a radiographic film for facility and patient ID information

Site specific markers

The value of the concept is not specified

Image quality deficiency according to MQSA

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency

Image quality deficiency

Image quality deficiency according to MQCM

Image quality deficiency according to MQSA

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQSA

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency according to MQCM

Image quality deficiency

Image quality deficiency according to MQCM

Signals that do not faithfully reproduce actual anatomic structures because of distortion or of addition or deletion of information

Feature(s) arising from the acquisition unit's anti-scatter grid mechanism. For two-dimensional systems, such features include those of mechanically damaged or incorrectly positioned grids. For moving or Bucky grids, artifacts may result from intentional grid motion that is inadequate in duration or velocity uniformity

Inadequate arrangement of the anatomy of interest with respect to the X-Ray field and image detector sensitive area. Examples: 1) positioning is "cutoff" when the projection of anatomy of interest falls outside the sensitive area of the detector; 2) "cone cut", in which the X-Ray field does not adequately cover the anatomy of interest; 3) detector's sensitive surface is too small to cover the projection of the anatomy of interest; 4) improper angular orientation or "rotation" of anatomy of interest with respect to the X-Ray source, or detector; 5) projection of other anatomy or clothing over the anatomy of interest in the image

Unacceptable image blur resulting from motion of the anatomy of interest during exposure or the inadequately compensated motion of X-Ray source with respect to the image detector during exposure

Inadequate number of quanta reached the detector during exposure. Reasons for under exposed images include low kVp, low mAs product, excess Source Image Distance. Under exposed images have inadequate signal and higher noise in the areas of interest

An excess number of quanta reached the detector during exposure. Reasons for over exposed images include high kVp, high mAs product, short Source Image Distance. Over exposed images have high signal and lower noise in the areas of interest. Over exposed area may demonstrate lack of contrast from over saturation of the detector

No evidence of a patient exposure

Superposed features or flaws of the detector

Features or discontinuities arising from causes other than the anti-scatter grid and image detector

Failure of the device to operate according to mechanical design specifications

Failure of a device to operate according to electrical design specifications

Attributable to software used in generation or handling of image

Images processed inappropriately, not following appropriate protocol

Failure that is not mechanical or electrical or otherwise described

Unidentified or unknown cause of failure

The attempted process was completely successful

The attempted process succeeded in some ways, but failed in others

The attempted process completely failed

No process was performed

Analysis of a related group of findings or features detected during image data inspection, to produce a summary impression and/or recommendation

Analysis of all groups of findings or features, to produce a single impression and/or recommendation

The usability of an image for diagnostic interpretation or CAD, based on a quality control standard

The usability of an image for diagnostic interpretation or CAD, based on a quality control standard

The usability of an image for diagnostic interpretation or CAD, based on a quality control standard

An image quality control standard specified by the American College of Radiology

An image quality control standard in the US Code of Federal Regulations

An image quality control standard specified or adopted by the institution responsible for the document

No findings resulted upon successful completion of all attempted computer-aided detection and/or analysis

One or more findings resulted upon successful completion of all attempted computer-aided detection and/or analysis

No findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process

One or more findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process

All of the attempted computer-aided detection and/or analysis failed, so there could be no findings

A benign tumor having glandular characteristics but composed of fat, with the presence of normal mammary ducts

Hyperplasia is also known as epithelial hyperplasia or proliferative breast disease. It's an overgrowth of the cells that line the ducts or the lobules. Based on how the cells look under a microscope, the hyperplasia is called either ductal hyperplasia (also called duct epithelial hyperplasia) or lobular hyperplasia. Based on the pattern of the cells, hyperplasia may be called usual or atypical. In usual hyperplasia, the pattern of cells is very close to normal. Atypical hyperplasia (or hyperplasia with atypia) is a term used when the cells are more distorted. FROM: http://www.cancer.org/healthy/findcancerearly/womenshealth/non-cancerousbreastconditions/non-cancerous-breast-conditions-hyperplasia

Neoplasms composed of myoepithelial cells

Axillary node that is normal in appearance with no associated pathology

Axillary node containing calcifications

Excessive proliferation of normal tissue arrangement of the axillary node

Cyst with benign morphology containing blood

Calcifications having typically benign morphology. They are not of intermediate or high probability of concern for malignancy

Growing within a cystic adenoma, filling the cavity with a mass of branching epithelial processes

Adenoma located in mammary duct, present as discrete sclerotic nodules, solitary or multiple

The occurrence of fibrous tumor-forming stromal proliferation in patients with diabetes mellitus

A deep seated firm tumor frequently occurring on the chest consisting of collagenous tissue that infiltrates surround muscle; frequently recurs but does not metastasize

A cyst formed of a mass of epithelial cells, as a result of trauma has been pushed beneath the epidermis. The cyst is lined with squamous epithelium and contains concentric layers or keratin

Excessive proliferation of fibroadenoma tissue

A lipoma with an abundant stroma of fibrous tissue

Retention cyst caused by occlusion of a lactiferous duct

A congenital anomaly that leads to a proliferation of blood vessels leading to a mass that resembles a neoplasm, not located in parenchymal areas but subcutaneous

Hyperplasia is also known as epithelial hyperplasia or proliferative breast disease. It's an overgrowth of the cells that line the ducts or the lobules. Based on how the cells look under a microscope, the hyperplasia is called either ductal hyperplasia (also called duct epithelial hyperplasia) or lobular hyperplasia. FROM: http://www.cancer.org/healthy/findcancerearly/womenshealth/non-cancerousbreastconditions/non-cancerous-breast-conditions-hyperplasia

A form of fibrocystic disease in young woman with florid and sclerosing adenosis that microscopically may suggest carcinoma

Enlarging masses during lactation. A circumscribed benign tumor composed primarily of glandular structures with scanty stroma, with prominent secretory changes in the duct

Changes related to the process of lactation

A papilloma pertaining to large mammary duct

Solitary or multiple tumors of muscles and fibrous tissues, or tumors composed of myofibroblasts

Irregular clusters of small tubules are present in adipose or fibrous tissue, resembling tubular carcinoma but lacking stromal fibroblastic proliferation

Papilloma typically involving an aggregate of adjacent ducts in the periphery of the breast, likely representing involvement of several foci of one or two duct systems

No abnormality

Normal breast tissue

Condition in which there are tumors of various sizes on peripheral nerves. They may be neuromas or fibromas

A cyst resulting from the loss of the epithelial lining of a sebaceous dermoid or lacteal cyst

Breast tissue with characteristics of a benign nature, following breast reduction surgery

A benign stromal lesion composed of intermixed stromal and epithelial elements. The lobular and duct structures of the breast parenchyma are separated by an increased amount of stroma, non specific proliferative epithelial changes include hyperplasia of duct and lobular epithelium often with accentuation of myoepithelial cells and aprocine metaplasia with or without cyst formation

An nonencapsulated stellate lesion consisting of a fibroelastic core and radiating bands of fibrous connective tissue containing lobules manifesting adenosis and ducts with papillary or diffuse intraductal hyperplasia

Prominent interductal fibrosis of the terminal ductules

Nodular inflammatory lesions due to the presence of silicone in the breast tissue

The morphologic status of the nipple

Spontaneous excessive proliferation of breast tissue, usually found in younger women

Papilloma(s) pertaining the peripheral ducts

Axillary node with lymphoid tissue neoplasm

Metastatic disease to the axillary node

A malignant neoplasm occurring most often in breast and skin, believed to originate from endothelial cells of blood vessels, microscopically composed of closely packed round or spindle shaped cells, some of which line small spaces resembling vascular clefts

Histological changes to the vascular system related to an invasive process

Carcinoma of the breast found in patients less than 20 years of age

A carcinoma found in supernumerary breasts and aberrant breast tissue

A carcinoma that synthesizes substances, including hormones, not considered to be normal products of the breast

A basal cell carcinoma that arises in the nipple of the breast

Metaplastic carcinoma is cancer that begins in cells that have changed into another cell type (for example, a squamous cell of the esophagus changing to resemble a cell of the stomach). In some cases, metaplastic changes alone may mean there is an increased chance of cancer developing at the site. Metaplastic carcinoma is a relatively uncommon type of cancer with treatment generally similar to that of invasive ductal carcinoma of no special type.[1] FROM: https://en.wikipedia.org/wiki/Metaplastic_carcinoma

Tissue changes to bones and cartilage

Carcinoma of the breast presenting during pregnancy or lactation

A malignant neoplasm that contains elements of carcinoma and sarcoma, so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue

Comedocarcinoma of a duct with areas of necrotic tissue

A non-invasive carcinoma restricted to the glandular lumen characterized by less aggressive malignant cytologic features and behavior

Papillary and micropapillary Ductal Carcinoma In Situ (DCIS): the cancer cells arrange themselves in a fern-like pattern within the affected breast ducts; micropapillary DCIS cells are smaller than papillary DCIS cells. FROM: http://www.imaginis.com/breast-cancer-diagnosis/ductal-carcinoma-in-situ-dcis-3

A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells found in a cyst

Carcinoma with both characteristics of localized and spreading disease

Invasive lobular carcinoma is a type of breast cancer that begins in the milk-producing glands (lobules) of the breast. Invasive cancer means the cancer cells have broken out of the lobule where they began and have the potential to spread to the lymph nodes and other areas of the body. Invasive lobular carcinoma typically doesn't form a lump, which is common in breast cancer. Instead, there is a change in the breast that feels like a thickening or fullness in one part of the breast and is different from the surrounding breast tissue. FROM: http://www.mayoclinic.org/diseases-conditions/invasive-lobular-carcinoma/basics/definition/con-20033968

Mammary infiltrates as a secondary manifestation in patients with established leukemia

Histological changes to the lymphatic system related to an invasive process

A heterogeneous group of neoplasms arising in the reticuloendoethelial and lymphatic systems

A small carcinoma, either asymptomatic or giving rise to metastases without symptoms due to the primary carcinoma presenting with metastatic disease in the axillary lymph nodes

A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a non-mammary malignant neoplasm

A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the colon

A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the lung

A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a melanoma

A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the ovary

A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a sarcoma

Multiple foci of non-invasive carcinoma restricted to the glandular lumen

A malignant lesion in an axillary node arising from a non-axillary neoplasm

Pleomorphic undifferentiated sarcoma (abbreviated PUS), also undifferentiated pleomorphic sarcoma and previously malignant fibrous histiocytoma (abbreviated MFH), is a type of soft tissue sarcoma. FROM: https://en.wikipedia.org/wiki/Pleomorphic_undifferentiated_sarcoma

Multiple sites of ductal carcinoma

A malignant lesion in a intramammary lymph node arising from a non-intramammary lymph node neoplasm

A malignant melanoma of the skin that arises in the nipple of the breast

Papillary and micropapillary Ductal Carcinoma In Situ (DCIS): the cancer cells arrange themselves in a fern-like pattern within the affected breast ducts; micropapillary DCIS cells are smaller than papillary DCIS cells. FROM: http://www.imaginis.com/breast-cancer-diagnosis/ductal-carcinoma-in-situ-dcis-3

Recurrent malignancy

Squamous cell carcinoma to the terminal portion of the alveolar

A non-invasive carcinoma restricted to the glandular lumen characterized by more aggressive malignant cytologic features and behavior

Invasive tumor with cribriform pattern similar to cribriform DCIS. Low grade, cribriform appearance (well defined spaces formed by arches of cells) similar to cribriform DCIS but with larger cells, more cytoplasm and more vesicular nuclei: Tumor cells are small, often have apical snouts, mild/moderate nuclear pleomorphism; Also stromal invasion by islands of cells, often angulated; May have predominantly solid appearance; Associated with cribriform DCIS; Often mixed with tubular carcinoma. FROM: http://www.pathologyoutlines.com/topic/breastmalignantcribriform.html

An indication that some or all of the margin of a lesion has sharp corners, often forming acute angles

Calcifications that vary in sizes and shapes and are usually smaller than0.5 mm in diameter

Coarse calcifications that are 0.5 mm or greater in size

An indicator that calcifications are imbedded within a mass

An indicator that calcifications are imaged outside of a mass finding

Tissue composition of the breast noted on sonography

Fat lobules and uniformly echogenic bands of supporting structures comprise the bulk of breast tissue

A uniformly echogenic layer of fibroglandular tissue is seen beneath a thin layer of subcutaneous fat

The breast texture is characterized by multiple small areas of increased and decreased echogenicity

Referential relationship of the finding to the imaging device as noted on sonography

The long axis of a lesion parallels the skin line ("wider-than-tall" or in a horizontal orientation)

The anterior-posterior or vertical dimension is greater than the transverse or horizontal dimension

The lesion boundary describes the transition zone between themas and the surrounding tissue

The sharp demarcation between the lesion and surrounding tissue can be imperceptible or a distinct well-defined echogenic rim of any thickness

There is no sharp demarcation between the mass and the surrounding tissue, which is bridged by an echogenic transition zone

An imaging characteristic of resonance noted during sonography

Without internal echoes

Having increased echogenicity relative to fat or equal to fibroglandular tissue

Mass contains both anechoic and echogenic components

Defined relative to fat; masses are characterized by low-level echoes throughout; e.g. appearance of a complicated cyst or fibroadenoma

Having the same echogenicity as fat (a complicated cyst or fibroadenoma may be isoechoic or hypoechoic)

The attenuation characteristics of a mass with respect to its acoustic transmission

No posterior shadowing or enhancement

Increased posterior echoes

Decreased posterior echoes; edge shadows are excluded

More than one pattern of posterior attenuation, both shadowing and enhancement

Sonographic appearance of adjacent structures relative to a mass finding

Characterization of vascularization in region of interest

Vascularity not evident, such as on ultrasound

Vascularity not evaluated

Vascularity on imaging is seen within a lesion

Vascularity on imaging is seen immediately adjacent to a lesion

Vascularity on imaging is considered diffusely elevated within the surrounding breast tissue

Relationship of the new anomaly to other clinical or imaging anomalies

An indication that the current imaging finding relates to a finding from a clinical breast exam

An indication that the current imaging finding relates to a finding from a mammography exam

An indication that the current imaging finding relates to a finding from a breast MRI exam

An indication that the current imaging finding relates to a finding from a breast ultrasound exam

An indication that the current imaging finding relates to a finding from an imaging exam

An indication that the current imaging finding has no relation to findings from any other imaging exam

An indication that the current imaging finding has no relation to any other clinical findings

Classification of the cancer as invasive, DCIS, or other

A malignancy that has spread beyond an area of focus

A breast cancer with malignant pathology findings that are not classified as invasive or in situ

A specific timeframe during menses

In the first week of the menstrual cycle phase, that is, one week following menses

In the second week of the menstrual cycle phase, that is, two weeks following menses

In the third week of the menstrual cycle phase, that is, three weeks following menses

An estimated period of time

An event occurred less than 3 months ago

An event occurred between 4 months and 1 year ago

An event occurred longer than 1 year ago

The timing of an event is not recalled

Report title for the diagnostic report for one or more breast imaging or intervention procedures

Concept name for the description of why a procedure has been performed

A finding during clinical examination (i.e., history and physical examination) such as pain, palpable mass or discharge

First screening mammogram taken for patient that is used as a comparison baseline for further examinations

First mammogram taken for a patient without regard to whether it was for screening or a diagnostic procedure

Concept name for the material of which a breast prosthetic device is constructed

A numeric count of findings classified as similar in nature

Concept name for the status of a breast prosthetic device as noted by imaging

Mammogram using traditional X-Ray film

Mammogram using a digital image acquisition system

Referred for evaluation by a surgeon

Computer aided detection and/or computer aided diagnosis for mammography

Concept name for a text-based section of a report

A title for a report section that summarizes all interpretation results for a report with one overriding assessment; e.g. benign or negative

Concept name for a collection of supporting evidence for a report

Prior study indicates that additional imaging be performed to further evaluate a suspicious or questionable anatomic region

The prior study recommended a follow-up breast imaging exam in 1 to 11 months (generally in 6 months)

Prior breast augmentation (breast enlargement) and is not presenting with any symptoms

Review or second opinion made on an image performed outside of the facility

Additional breast imaging performed at the time of the patient's screening mammogram

Patient has had previous benign breast biopsies

Patient has had a prior surgery such as a lumpectomy or quadrantectomy to remove malignant breast tissue, but breast tissue remains

The results of a physical examination performed on the patient, possibly including the results of inspection, palpation, auscultation, or percussion

The result of assessing the current imaging exam in comparison to previous imaging exams

An abnormality observed during ductography where the ductal system within the breast fills in an abnormal pattern. Ductography is an imaging exam in which a radio opaque contrast media is introduced into the ductal system of the breast through the nipple and images of the ductal system are obtained

During ductography an observation of more than one filling abnormality within the breast ductal system

An abnormality observed during ductography where the ductal system within the breast terminates in an unusual fashion

Abnormal flowage of contrast media within the breast noted on ductography

An abnormality observed during ductography where the ductal system within the breast appears narrow

During ductography an observation of the contrast media filling a cyst within the breast

The area and line within the anatomy through which a needle or instrument passes during an interventional procedure

The line within the anatomy from the lower outer to the upper inner aspect; e.g. through which a needle or instrument passes in an interventional procedure

The line within the anatomy from the lower inner to the upper outer aspect; e.g. through which a needle or instrument passes in an interventional procedure

The line within the anatomy from the upper outer to the lower inner aspect; e.g. through which a needle or instrument passes in an interventional procedure

The line within the anatomy from the upper inner to the lower outer aspect; e.g. through which a needle or instrument passes in an interventional procedure

The number of times a biopsy instrument is passed through an area of interest

The number of biopsy specimens obtained from an interventional procedure

An indicator of whether or not a biopsy or localizing needle in an interventional procedure is seen to be in the area of interest

The number of localizing needles placed around the area of interest in an interventional procedure

An indicator of whether or not an incision was made in the anatomy during an interventional procedure

An indicator of whether or not a radio opaque microclip was placed in the anatomy during an interventional procedure

An indicator of the degree of success of an interventional procedure

An indicator that during an interventional procedure the area of interest was fully excised and is noted in the resultant biopsy specimen

An indicator that during an interventional procedure the area of interest was partially excised and is noted in the resultant biopsy specimen

An indicator that following an interventional procedure the area of interest is not seen in the resultant biopsy specimen

An indicator that following an interventional procedure the targeted calcifications are noted in the resultant biopsy specimen

An indicator that during an interventional procedure the area of interest was fully excised and is noted in the resultant biopsy specimen

An indicator that during an interventional procedure the area of interest was partially excised and is noted in the resultant biopsy specimen

An indicator that during an interventional procedure fluid was successfully aspirated

Color that is a light shade of brown

Color that is a dark shade of red

Color that is a dark shade of brown

Color that is a bright shade of red

Color that is tinged with the color of blood

An indicator of whether or not the fluid obtained during an interventional procedure contains red blood cells

An indicator of whether or not fluid during an interventional procedure was sent for cytological analysis or simply discarded

An indicator that fluid obtained during an interventional procedure was sent to a laboratory for analysis

An indicator that fluid obtained during an interventional procedure was discarded

A radiopaque density noted during diagnostic imaging that has associated calcific densities

A fluid-filled sac with greater than normal characteristics

A tumor within a cyst

A tumor or lesion

Supporting evidence for interpretation results of an interventional procedure

A descriptor that further qualifies or characterizes a type of procedure

Needle size (diameter) characterization; e.g. of a biopsy needle

An indicator of the gravity of a problem experienced by a patient, related to a procedure that was performed

Distance from the hub or bushing to the tip of the needle

The collection of observations and findings from pathologic analysis

The date and time that the sample was collected from the patient

Indicates that the margin of the biopsy specimen was not involved with the tumor

Indicates that the margin of the biopsy specimen was involved with the tumor

Indicates whether the nipple was involved in an interventional procedure or pathologic analysis

Indicates the number of lymph nodes removed

Indicates the number of lymph nodes removed that contain cancer cells

The result of a test for the presence of a protein that binds with estrogen

The result of a test for the presence of a protein that binds with progesterone

Indicates the percentage of cells in S phase. Cell division is defined by phases; the S phase is the stage during which DNA replicates

The visible emission of non-bloody fluid from the nipple

The inability to discern normal versus abnormal breast tissue during palpation

An indication that a patient has or had a malignant occurrence in an area of the body other than the breast

A salt water filled prosthetic device implanted in the breast

A polymer based (plastic) prosthetic device implanted in the breast

The introduction of polymeric organic silicon based material through the skin, as for breast augmentation or reconstruction

A prosthetic device that contains more than one material implanted in the breast

A breast implant placed in front of the pectoralis major muscle

A breast implant placed behind the pectoralis major muscle

Using X-Ray technique and a superimposed set of crossed lines for detection or placement

Using X-Ray technique and a superimposed aperture for detection or placement

Using physical touch for detection or placement

The performance of a biopsy procedure using a vacuum device attached to the biopsy needle

Unusual or unexpected emission of fluid

Having experienced no adverse medical conditions related to or resulting from an interventional procedure

TNM grouping of tumor stage, from AJCC, where primary tumor is Tis, regional lymph node is N0, and distant metastasis is M0

TNM grouping of tumor stage, from AJCC, where primary tumor is T1, regional lymph node is N0, and distant metastasis is M0

TNM grouping of tumor stage, from AJCC, where primary tumor is T0 or T1, with regional lymph node N1 and distant metastasis is M0, or T2 with N0 and M0

TNM grouping of tumor stage, from AJCC, where primary tumor is T2, with regional lymph node N1 and distant metastasis is M0, or T3 with N0 and M0

TNM grouping of tumor stage, from AJCC, where primary tumor is T0, T1 or T2, with regional lymph node N2 and distant metastasis is M0, or T3 with N1 or N2 and M0

TNM grouping of tumor stage, from AJCC, where primary tumor is T4, regional lymph node is N0, N1 or N2, and distant metastasis is M0

TNM grouping of tumor stage, from AJCC, where primary tumor is any T value, regional lymph node is N3, and distant metastasis is M0

TNM grouping of tumor stage, from AJCC, where primary tumor is any T value, regional lymph node is any N value, and distant metastasis is M1

Histologic tumor grade (sometimes called Scarff-Bloom-Richardson grade) is based on the arrangement of the cells in relation to each other -- whether they form tubules, how closely they resemble normal breast cells (nuclear grade) and how many of the cancer cells are in the process of dividing (mitotic count)

Breast prosthetic devices are intact, not leaking, and are in a normal shape and form

Breast prosthetic devices are not symmetric, equal, corresponding in form, or are in one breast (unilateral)

Fibrous or calcific contracture of the tissue capsule that forms around a breast prosthetic device

Breast prosthetic device is twisted out of normal shape or form

Silicone from breast prosthetic device found in lymphatic tissue

Silicone found in breast tissue outside of the prosthetic capsule or implant membrane

Protrusion of part of the structure normally encapsulating the content of the breast prosthetic device

Evidence of removal of a breast prosthetic device

Historical patient health information of interest to the breast health clinician

Information regarding usage by the patient of certain medications, such as hormones

Interventional or non-interventional procedures previously performed on the patient, such as breast biopsies